Page 345 - Small Caps News Today

Brokers raise valuations for Neuren Pharmaceuticals following positive Phase 2 clinical trial results

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

In the January issue, I wrote that given the enormous gains enjoyed by so many stocks in the final months of 2023, it would not be surprising to see the selling [...]

"Small caps relative to the S&P 500 on a price-to-book basis is back to where it was in 1999," Fundstrat's Tom Lee said on Tuesday.

The Eaton Vance Atlanta Capital SMID-Cap fund isn’t forced to sell off its winners when they get too big. Its low turnover helps, too.

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

Learn how to make a WordPress site look professional in just 7 steps. From creating a clear brand identity to designing a responsive site, this blog post covers everything you need to attract and delight your visitors.

Small cap stocks have ripped higher as investors have increasingly bet on interest rate cuts in 2024.

Small cap stocks have ripped higher as investors have increasingly bet on interest rate cuts in 2024.

Investors are looking to big bank quarterly results and retail data to keep the momentum from stocks' weekly win going.